Laboratory Findings Associated With Severe Illness and Mortality Among Hospitalized Individuals With Coronavirus Disease 2019 in Eastern Massachusetts

被引:28
|
作者
Castro, Victor M. [1 ,2 ]
McCoy, Thomas H. [1 ]
Perlis, Roy H. [1 ]
机构
[1] Massachusetts Gen Hosp, Ctr Quantitat Hlth, Div Clin Res, 185 Cambridge St,6th Floor, Boston, MA 02114 USA
[2] Mass Gen Brigham, Res Informat Sci & Comp, Somerville, MA USA
关键词
COVID-19;
D O I
10.1001/jamanetworkopen.2020.23934
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Importance The coronavirus disease 2019 (COVID-19) pandemic has placed unprecedented stress on health systems across the world, and reliable estimates of risk for adverse hospital outcomes are needed. Objective To quantify admission laboratory and comorbidity features associated with critical illness and mortality risk across 6 Eastern Massachusetts hospitals. Design, Setting, and Participants Retrospective cohort study of all individuals admitted to the hospital who tested positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by polymerase chain reaction across these 6 hospitals through June 5, 2020, using hospital course, prior diagnoses, and laboratory values in emergency department and inpatient settings from 2 academic medical centers and 4 community hospitals. The data were extracted on June 11, 2020, and the analysis was conducted from June to July 2020. Exposures SARS-CoV-2. Main Outcomes and Measures Severe illness defined by admission to intensive care unit, mechanical ventilation, or death. Results Of 2511 hospitalized individuals who tested positive for SARS-CoV-2 (of whom 50.9% were male, 53.9% White, and 27.0% Hispanic, with a mean [SD ]age of 62.6 [19.0] years), 215 (8.6%) were admitted to the intensive care unit, 164 (6.5%) required mechanical ventilation, and 292 (11.6%) died. L1-regression models developed in 3 of these hospitals yielded an area under the receiver operating characteristic curve of 0.807 for severe illness and 0.847 for mortality in the 3 held-out hospitals. In total, 212 of 292 deaths (72.6%) occurred in the highest-risk mortality quintile. Conclusions and Relevance In this cohort, specific admission laboratory studies in concert with sociodemographic features and prior diagnosis facilitated risk stratification among individuals hospitalized for COVID-19. Question How well can sociodemographic features, laboratory values, and comorbidities of individuals hospitalized with coronavirus disease 2019 (COVID-19) in Eastern Massachusetts through June 5, 2020, predict a severe illness course? Findings In this cohort study of 2511 hospitalized individuals positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by polymerase chain reaction who were admitted to 1 of 6 hospitals, 215 (8.6%) were admitted to the instensive care unit, 164 (6.5%) required mechanical ventilation, and 292 (11.6%) died. In a risk prediction model, 212 deaths (78%) occurred in the top mortality-risk quintile. Meaning Simple prediction models may assist in risk stratification among hospitalized patients with COVID-19. This cohort study assesses admission laboratory and comorbidity features associated with critical illness and mortality risk among patients hospitalized with coronavirus disease 2019 (COVID-19) across 6 Eastern Massachusetts hospitals.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Laboratory and demographic findings among patients with coronavirus disease 2019: a review
    Mir, Atefeh
    Farmanfarma, Khadijeh Kalan
    Salehiniya, Hamid
    Shakiba, Abolfazl
    Mahdavifar, Neda
    Kiasara, Somayeh Heidarpour
    MONALDI ARCHIVES FOR CHEST DISEASE, 2021, 91 (04)
  • [2] Viral Load Kinetics of Severe Acute Respiratory Syndrome Coronavirus 2 in Hospitalized Individuals With Coronavirus Disease 2019
    Regan, James
    Flynn, James P.
    Rosenthal, Alexandra
    Jordan, Hannah
    Li, Yijia
    Chishti, Rida
    Giguel, Francoise
    Corry, Heather
    Coxen, Kendyll
    Fajnzylber, Jesse
    Gillespie, Elizabeth
    Kuritzkes, Daniel R.
    Hacohen, Nir
    Goldberg, Marcia B.
    Filbin, Michael R.
    Yu, Xu G.
    Baden, Lindsey
    Ribeiro, Ruy M.
    Perelson, Alan S.
    Conway, Jessica M.
    Li, Jonathan Z.
    OPEN FORUM INFECTIOUS DISEASES, 2021, 8 (08):
  • [3] Association of administration of IFN-α with mortality among patients hospitalized with coronavirus disease 2019
    Liu, Hanqing
    Ruan, Zhouru
    Yin, Ziwei
    Wu, Dan
    Zhu, Hong
    FUTURE VIROLOGY, 2021, 16 (03) : 201 - 209
  • [4] Delayed Mortality Among Solid Organ Transplant Recipients Hospitalized for Coronavirus Disease 2019
    Heldman, Madeleine R.
    Kates, Olivia S.
    Safa, Kassem
    Kotton, Camille N.
    Multani, Ashrit
    Georgia, Sarah J.
    Steinbrink, Julie M.
    Alexander, Barbara D.
    Blumberg, Emily A.
    Haydel, Brandy
    Hemmige, Vagish
    Hemmersbach-Miller, Marion
    La Hoz, Ricardo M.
    Moni, Lisset
    Condor, Yesabeli
    Flores, Sandra
    Munoz, Carlos G.
    Guitierrez, Juan
    Diaz, Esther, I
    Diaz, Daniela
    Vianna, Rodrigo
    Guerra, Giselle
    Loebe, Matthias
    Yabu, Julie M.
    Kramer, Kailey Hughes
    Tanna, Sajal D.
    Ison, Michael G.
    Rakita, Robert M.
    Malinis, Maricar
    Azar, Marwan M.
    McCort, Margaret E.
    Singh, Pooja P.
    Velioglu, Arzu
    Mehta, Sapna A.
    van Duin, David
    Goldman, Jason D.
    Lease, Erika D.
    Wald, Anna
    Limaye, Ajit P.
    Fisher, Cynthia E.
    CLINICAL INFECTIOUS DISEASES, 2024, 78 (03) : 711 - 718
  • [5] Correspondence to Morbidity and Mortality Among Adults Experiencing Homelessness Hospitalized With Coronavirus Disease 2019
    Chang, Yun-Hsin
    Kao, Chi-Ching
    Fang, Jia-Jun
    Lee, Yung-Heng
    Cheng-Chung Wei, James
    JOURNAL OF INFECTIOUS DISEASES, 2022, 225 (12): : 2235 - 2235
  • [6] Impact of Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load on Risk of Intubation and Mortality Among Hospitalized Patients With Coronavirus Disease 2019
    Magleby, Reed
    Westblade, Lars F.
    Trzebucki, Alex
    Simon, Matthew S.
    Rajan, Mangala
    Park, Joel
    Goyal, Parag
    Safford, Monika M.
    Satlin, Michael J.
    CLINICAL INFECTIOUS DISEASES, 2021, 73 (11) : E4197 - E4205
  • [7] Environmental and Aerosolized Severe Acute Respiratory Syndrome Coronavirus 2 Among Hospitalized Coronavirus Disease 2019 Patients
    Binder, Raquel A.
    Alarja, Natalie A.
    Robie, Emily R.
    Kochek, Kara E.
    Xiu, Leshan
    Rocha-Melogno, Lucas
    Abdelgadir, Anfal
    Goli, Sumana, V
    Farrell, Amanda S.
    Coleman, Kristen K.
    Turner, Abigail L.
    Lautredou, Cassandra C.
    Lednicky, John A.
    Lee, Mark J.
    Polage, Christopher R.
    Simmons, Ryan A.
    Deshusses, Marc A.
    Anderson, Benjamin D.
    Gray, Gregory C.
    JOURNAL OF INFECTIOUS DISEASES, 2020, 222 (11): : 1798 - 1806
  • [8] Risk Factors for Mortality in Hospitalized Coronavirus Disease 2019 Patients
    Dietl, Beatriz
    Martinez-Camblor, Pablo
    Almagro, Pere
    Boix-Palop, Lucia
    Gomez, Lucia
    Cairo, Mireia
    Calbo, Esther
    Barreiro, Bienvenido
    Martinez, Laura Maria
    Trenado, Josep
    Malik, Komal
    Castrillo, Cristina
    de la Asuncion, Maria Jose
    Grau, Gemma
    Llargues, Oriol
    Mateu, Aina
    Meza, Franklyn Ferney
    Libori-Roch, Ginebra
    Molina, Siena
    Clemente, David
    Martinez-Urrea, Ana
    Moreno-Lopez, Tere
    Simon-Pascua, Lluis
    Gisbert, Laura M.
    CHEST, 2020, 158 (06) : 2699 - 2700
  • [9] Neurological manifestations and mortality in hospitalized coronavirus disease 2019 patients
    Ozel, Tugba
    Erdem, Nazan Simsek
    Unal, Ali
    Yalcin, Ata Nevzat
    Inan, Dilara
    Ilhanli, Nevruz
    Uysal, Hilmi
    NEUROLOGICAL SCIENCES AND NEUROPHYSIOLOGY, 2022, 39 (03): : 138 - 145
  • [10] Severe Acute Respiratory Syndrome Coronavirus 2 RNA in Plasma Is Associated With Intensive Care Unit Admission and Mortality in Patients Hospitalized With Coronavirus Disease 2019
    Prebensen, Christian
    Myhre, Peder L.
    Jonassen, Christine
    Rangberg, Anbjorg
    Blomfeldt, Anita
    Svensson, My
    Omland, Torbjorn
    Berdal, Jan-Erik
    CLINICAL INFECTIOUS DISEASES, 2021, 73 (03) : E799 - E802